286 related articles for article (PubMed ID: 24170027)
21.
Close V; Close W; Kugler SJ; Reichenzeller M; Yosifov DY; Bloehdorn J; Pan L; Tausch E; Westhoff MA; Döhner H; Stilgenbauer S; Oswald F; Mertens D
Blood; 2019 Feb; 133(8):830-839. PubMed ID: 30510140
[No Abstract] [Full Text] [Related]
22. Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.
Nadeu F; Delgado J; Royo C; Baumann T; Stankovic T; Pinyol M; Jares P; Navarro A; Martín-García D; Beà S; Salaverria I; Oldreive C; Aymerich M; Suárez-Cisneros H; Rozman M; Villamor N; Colomer D; López-Guillermo A; González M; Alcoceba M; Terol MJ; Colado E; Puente XS; López-Otín C; Enjuanes A; Campo E
Blood; 2016 Apr; 127(17):2122-30. PubMed ID: 26837699
[TBL] [Abstract][Full Text] [Related]
23. Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia.
Jelloul FZ; Yang R; Garces S; Kanagal-Shamanna R; Ok CY; Loghavi S; Routbort MJ; Zuo Z; Yin CC; Floyd K; Bassett RL; Wierda W; Jain N; Thompson P; Luthra R; Medeiros LJ; Patel KP
Leuk Res; 2022 May; 116():106827. PubMed ID: 35430388
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the 3'UTR region of the NOTCH1 gene in chronic lymphocytic leukemia patients.
Abramenko IV; Bilous NI; Chumak AA; Dyagil IS; Martina ZV
Exp Oncol; 2018 Oct; 40(3):211-217. PubMed ID: 30284999
[TBL] [Abstract][Full Text] [Related]
25. Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells.
López-Guerra M; Xargay-Torrent S; Fuentes P; Roldán J; González-Farré B; Rosich L; Silkenstedt E; García-León MJ; Lee-Vergés E; Giménez N; Giró A; Aymerich M; Villamor N; Delgado J; López-Guillermo A; Puente XS; Campo E; Toribio ML; Colomer D
Oncogene; 2020 Feb; 39(6):1185-1197. PubMed ID: 31616059
[TBL] [Abstract][Full Text] [Related]
26. Clinical Value of NOTCH1 Mutations Detection among Chronic Lymphocytic Leukemia Patients.
Aref S; El-Agder M; Salama O; Abouzeid T; Sabry M
Asian Pac J Cancer Prev; 2020 May; 21(5):1295-1301. PubMed ID: 32458636
[TBL] [Abstract][Full Text] [Related]
27. B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities.
Falisi E; Novella E; Visco C; Guercini N; Maura F; Giaretta I; Pomponi F; Nichele I; Finotto S; Montaldi A; Neri A; Rodeghiero F
Hematol Oncol; 2014 Mar; 32(1):22-30. PubMed ID: 23861036
[TBL] [Abstract][Full Text] [Related]
28. Fragment analysis represents a suitable approach for the detection of hotspot c.7541_7542delCT NOTCH1 mutation in chronic lymphocytic leukemia.
Vavrova E; Kantorova B; Vonkova B; Kabathova J; Skuhrova-Francova H; Diviskova E; Letocha O; Kotaskova J; Brychtova Y; Doubek M; Mayer J; Pospisilova S
Leuk Res; 2017 Sep; 60():145-150. PubMed ID: 28837890
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.
Fabbri G; Rasi S; Rossi D; Trifonov V; Khiabanian H; Ma J; Grunn A; Fangazio M; Capello D; Monti S; Cresta S; Gargiulo E; Forconi F; Guarini A; Arcaini L; Paulli M; Laurenti L; Larocca LM; Marasca R; Gattei V; Oscier D; Bertoni F; Mullighan CG; Foá R; Pasqualucci L; Rabadan R; Dalla-Favera R; Gaidano G
J Exp Med; 2011 Jul; 208(7):1389-401. PubMed ID: 21670202
[TBL] [Abstract][Full Text] [Related]
30. Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia.
Del Papa B; Baldoni S; Dorillo E; De Falco F; Rompietti C; Cecchini D; Cantelmi MG; Sorcini D; Nogarotto M; Adamo FM; Mezzasoma F; Silva Barcelos EC; Albi E; Iacucci Ostini R; Di Tommaso A; Marra A; Montanaro G; Martelli MP; Falzetti F; Di Ianni M; Rosati E; Sportoletti P
Clin Cancer Res; 2019 Dec; 25(24):7540-7553. PubMed ID: 31578228
[TBL] [Abstract][Full Text] [Related]
31. Hes1 Controls Proliferation and Apoptosis in Chronic Lymphoblastic Leukemia Cells by Modulating PTEN Expression.
Zhang Q; Zhu Z; Guan J; Hu Y; Zhou W; Ye W; Lin B; Weng S; Chen Y; Zheng C
Mol Biotechnol; 2022 Dec; 64(12):1419-1430. PubMed ID: 35704163
[TBL] [Abstract][Full Text] [Related]
32. NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome.
Villamor N; Conde L; Martínez-Trillos A; Cazorla M; Navarro A; Beà S; López C; Colomer D; Pinyol M; Aymerich M; Rozman M; Abrisqueta P; Baumann T; Delgado J; Giné E; González-Díaz M; Hernández JM; Colado E; Payer AR; Rayon C; Navarro B; José Terol M; Bosch F; Quesada V; Puente XS; López-Otín C; Jares P; Pereira A; Campo E; López-Guillermo A
Leukemia; 2013 Apr; 27(5):1100-6. PubMed ID: 23295735
[TBL] [Abstract][Full Text] [Related]
33. Mutations in NOTCH1 PEST domain orchestrate CCL19-driven homing of chronic lymphocytic leukemia cells by modulating the tumor suppressor gene DUSP22.
Arruga F; Gizdic B; Bologna C; Cignetto S; Buonincontri R; Serra S; Vaisitti T; Gizzi K; Vitale N; Garaffo G; Mereu E; Diop F; Neri F; Incarnato D; Coscia M; Allan J; Piva R; Oliviero S; Furman RR; Rossi D; Gaidano G; Deaglio S
Leukemia; 2017 Sep; 31(9):1882-1893. PubMed ID: 28017968
[TBL] [Abstract][Full Text] [Related]
34. NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment.
Bo MD; Del Principe MI; Pozzo F; Ragusa D; Bulian P; Rossi D; Capelli G; Rossi FM; Niscola P; Buccisano F; Bomben R; Zucchetto A; Maurillo L; de Fabritiis P; Amadori S; Gaidano G; Gattei V; Del Poeta G
Ann Hematol; 2014 Oct; 93(10):1765-74. PubMed ID: 24923451
[TBL] [Abstract][Full Text] [Related]
35. Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations.
Riches JC; O'Donovan CJ; Kingdon SJ; McClanahan F; Clear AJ; Neuberg DS; Werner L; Croce CM; Ramsay AG; Rassenti LZ; Kipps TJ; Gribben JG
Blood; 2014 Jun; 123(26):4101-10. PubMed ID: 24829201
[TBL] [Abstract][Full Text] [Related]
36. Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia.
Baldoni S; Del Papa B; Dorillo E; Aureli P; De Falco F; Rompietti C; Sorcini D; Varasano E; Cecchini D; Zei T; Di Tommaso A; Rosati E; Alexe G; Roti G; Stegmaier K; Di Ianni M; Falzetti F; Sportoletti P
Int J Cancer; 2018 Aug; 143(4):958-970. PubMed ID: 29508386
[TBL] [Abstract][Full Text] [Related]
37. NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients.
Willander K; Dutta RK; Ungerbäck J; Gunnarsson R; Juliusson G; Fredrikson M; Linderholm M; Söderkvist P
BMC Cancer; 2013 Jun; 13():274. PubMed ID: 23734977
[TBL] [Abstract][Full Text] [Related]
38.
Silva Barcelos EC; Rompietti C; Adamo FM; Dorillo E; De Falco F; Del Papa B; Baldoni S; Nogarotto M; Esposito A; Capoccia S; Geraci C; Sorcini D; Stella A; Arcaleni R; Tini V; Imbroisi Valle Errera F; Rosati E; Sportoletti P
Front Oncol; 2023; 13():1218989. PubMed ID: 37817771
[TBL] [Abstract][Full Text] [Related]
39. LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.
Kristensen L; Kristensen T; Abildgaard N; Royo C; Frederiksen M; Mourits-Andersen T; Campo E; Møller MB
Eur J Haematol; 2016 Aug; 97(2):175-82. PubMed ID: 26558352
[TBL] [Abstract][Full Text] [Related]
40. Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia.
Minervini A; Francesco Minervini C; Anelli L; Zagaria A; Casieri P; Coccaro N; Cumbo C; Tota G; Impera L; Orsini P; Brunetti C; Giordano A; Specchia G; Albano F
Oncotarget; 2016 Dec; 7(52):86469-86479. PubMed ID: 27835908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
